Syne-1 Inhibitors

The inhibitors listed above are primarily compounds that can indirectly influence the function of SYNE1 by modulating the dynamics of the cytoskeleton or associated signaling pathways. SYNE1 is crucial for connecting the nuclear envelope to the cytoskeleton, and its function is closely tied to the mechanical properties and structural integrity of the cell. Compounds like Blebbistatin, Y-27632, and ML-7 target elements of the cytoskeletal machinery, such as non-muscle myosin II, Rho-associated protein kinase (ROCK), and myosin light chain kinase (MLCK), respectively. By modulating these targets, these inhibitors can indirectly affect SYNE1's role in linking the nucleus to the cytoskeleton.

Actin dynamics, which are essential for maintaining cellular structure and function, can be influenced by compounds like Cytochalasin D, Jasplakinolide, and Latrunculin B. These compounds disrupt or stabilize actin filaments, thereby potentially impacting SYNE1's function in maintaining nuclear architecture and positioning. Microtubule-targeting agents such as Paclitaxel and Nocodazole also play a role in cellular mechanics and structure. By stabilizing or disrupting microtubules, they could indirectly influence the mechanical environment in which SYNE1 operates. Additionally, compounds like CCG-1423, NSC 23766, Forskolin, and Wiskostatin affect various signaling pathways and cytoskeletal elements that may interact with or influence SYNE1 function.